Ticker
GOSSCompany Name
GOSSAMER BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 240.93M | $ 26.31M | 10.92% |
3/31/2025 | $ 280.59M | $ 29.02M | 10.34% |
12/31/2024 | $ 315.29M | $ 46.07M | 14.61% |
9/30/2024 | $ 350.88M | $ 28.46M | 8.11% |
6/30/2024 | $ 373.45M | $ 86.88M | 23.26% |
3/31/2024 | $ 259.36M | $ 38.86M | 14.98% |
12/31/2023 | $ 311.92M | $ 32.11M | 10.29% |
9/30/2023 | $ 347.93M | $ 82.61M | 23.74% |
6/30/2023 | $ 181.75M | $ 37M | 20.36% |
3/31/2023 | $ 219.91M | $ 65.24M | 29.67% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for GOSSAMER BIO INC is calculated as follows: CashnEq [ $ 461.96M ] / Assets [ $ 584.18M ]
(=) Cash to Assets [ 79.08% ]
Minimum
Sep 30, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |